Dr. Mittendorf on Nelipepimut-S Plus GM-CSF in Breast Cancer

Elizabeth A. Mittendorf, MD, PhD
Published: Friday, Mar 11, 2016



Elizabeth A. Mittendorf, MD, PhD, associate professor, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, discusses a clinical trial examining nelipepimut-S plus GM-CSF vaccine therapy as a treatment for patients with breast cancer.

This HER2-derived peptide vaccine is immunogeneic and aimed to prevent disease recurrence, explains Mittendorf. In combination with GM-CSF, the strategy is to inoculate patients who are rendered disease-free with their standard therapy. The goal is to stimulate an immune response to help prevent recurrence.

Earlier phase studies show that the vaccine strategy has decreased recurrence rates by approximately 50%. This could potentially lead to an FDA approval of the combination.

<<< View more from the 33rd Annual Miami Breast Cancer Conference



Elizabeth A. Mittendorf, MD, PhD, associate professor, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, discusses a clinical trial examining nelipepimut-S plus GM-CSF vaccine therapy as a treatment for patients with breast cancer.

This HER2-derived peptide vaccine is immunogeneic and aimed to prevent disease recurrence, explains Mittendorf. In combination with GM-CSF, the strategy is to inoculate patients who are rendered disease-free with their standard therapy. The goal is to stimulate an immune response to help prevent recurrence.

Earlier phase studies show that the vaccine strategy has decreased recurrence rates by approximately 50%. This could potentially lead to an FDA approval of the combination.

<<< View more from the 33rd Annual Miami Breast Cancer Conference




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 18th Annual International Lung Cancer Congress®Oct 31, 20181.5
Provider and Caregiver Connection™: Addressing Patient Concerns While Managing Chemotherapy Induced Nausea and VomitingOct 31, 20182.0
Publication Bottom Border
Border Publication
x